Use of street methadone in italian heroin addicts presenting for Opioid agonist treatment

Journal of Addictive Diseases

Volumn 28, Issue 4, 2009, Pages 382-388

  Maremmani, Icro ^a,b,c   Pacini, Matteo ^b   Pani, Pier Paolo ^d   Popovic, Dina ^a   Romano, Anna ^e   Maremmani, Angelo G I ^c   Deltito, Joseph ^b,f   Perugi, Giulio ^b,e  

^a UNIVERSITY OF PISA   (Italy)

^b G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

^c From Science to Public Policy Association Pietrasanta   (Italy)

^d Office of Social Policies   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Agonist opioid treatment; Methadone diversion; Street methadone

Indexed keywords

DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HARM REDUCTION; HEALTH CARE UTILIZATION; HEROIN DEPENDENCE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; SELF MEDICATION;

ADULT; ANALGESICS, OPIOID; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEROIN DEPENDENCE; HOSPITALS, UNIVERSITY; HUMANS; INTERVIEW, PSYCHOLOGICAL; ITALY; LOGISTIC MODELS; MALE; METHADONE; MIDDLE AGED; NARCOTIC ANTAGONISTS; SEX DISTRIBUTION; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 75149185389     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550880903183000     Document Type: Article

References (24)

1. Schifano F, Bargagli AM, Belleudi V, Amato, L, Davoli, M, Diecidue R, Versino E, Vigna-Taglianti F, Faggiano F, Perucci CA.Methadone treatment in clinical practice in Italy: need for improvement. Eur Addict Res 2006; 12:121-127
2. Dole VP. Implications of methadone maintenance for theories of narcotic addiction. JAMA 1988; 260:3025-3029
3. Barnett PG, Hui SS. The cost-effectiveness of methadone maintenance. Mt Sinai J Med 2000; 67:365-374
4. Dole VP. What have we learned from three decades of methadone maintenance treatment. Drug Alcohol Rev 1994; 13:330-338
5. Kreek MJ, Khuri E, Fahey L, Miescher A, Arns P, Spagnoli D, Craig J, Millman R, Harte, EH. Long-term followup studies of the medical status of adolescent former heroin addicts in chronic methadone maintenance treatment: liver disease and immune status. NIDA Res Monogr 1986; 67:307-309.
6. Novick DM, Joseph H, Salsitz EA. Outcomes of treatment of socially rehabilited MMP in physicians'office (Medical Maintenance): follow-up at three and half to nine and a fourth years. J Gen Intern Med 1994; 9:127-130
7. Caplehorn JRM, Dalton MS, Cluff MC, Petrenas A. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994: 203-207
8. Dole VP. Research on methadone maintenance treatment. Int J Addict 1970; 5:360-363
9. Magura S, Nwakeze PC, Kang SY, Demsky S. Program quality effects on patients outcomes during methadone maintenance: a study of 17 clinics. Subst Use Misuse 1999; 34:1299-1324
10. Isbell H, Vogel VH. The addiction liability of methadon (amidone, dolophine, 10820) and its use in the treatment of the morphine abstinence syndrome. Am J Psychiatry 1949; 105:909-914
11. Weppner RS, Stephens RC, Conrad HT.Methadone: some aspects of its legal and illegal use. Am J Psychiatry 1972; 129:451-455
12. Ritter A, Di Natale R. The relationship between take-away methadone policies and methadone diversion. Drug Alcohol Rev 2005; 24:347-352
13. Berger H. Prevention of the diversion of clinic methadone to the street market. Proc Natl Conf Methadone Treat 1973; 2:1264-1266
14. Bourne PG. Methadone diversion. Proc Natl Conf Methadone Treat 1973; 2:839-841
15. Resnick RB. Problems of methadone diversion and implications for control. Int J Addict 1977; 12:803-806
16. Goldman FR, Thistel CI. Diversion of methadone: illicit methadone use among applicants to twometropolitan drug abuse programs. Int J Addict 1978; 13:855-862
17. Hough G, Washton AM, Resnick RB. Addressing the diversion of take-home methadone: LAAM as the sole treatment choice for patients seeking maintenance therapy. NIDA Res Monogr 1983; 43:302-309
18. Winstock AR, Lea T, Sheridan J. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. Int J Drug Policy 2008; 19:450-458
19. Maremmani I, Pacini M, Pani PP, Perugi G, Deltito J, Akiskal H. The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a "dual diagnosis?" Ann Gen Psychiatry 2007; 6:31.
20. Maremmani I, Castrogiovanni P. DAH-RS: Drug addiction history rating scale. Pisa: University Press, 1989.
21. Maremmani I, Pani PP, Mellini A, Pacini M, Marini G, Lovrecic M, Perugi G, Shinderman, MS. Alcohol and cocaine use and abuse among heroin addicts engaged in a methadone maintenance treatment program. J Addict Dis 2007; 26:61-70.
22. Maremmani I, Shinderman MS. Alcohol, benzodiazepines and other drugs use in heroin addicts treated with methadone. Polyabuse or undermedication? Heroin Addict Relat Clin Probl 1999; 1:7-13.
23. Verebey KE. Opioids in mental illness: theories, clinical observations and treatment possibilities. Ann NY Acad Sci 1982; 398.
24. Kreek MJ. Pharmacological treatment of addiction: normalization of physiology and AIDS risk reduction. In: Tagliamonte A, Maremmani I. eds. Drug addiction and related clinical problems. New York: Springer Verlag, 1995: 165-174